• Tigecycline Workflows for MDR Research

  2026-09-14

  Tigecycline provides a practical glycylcycline antibiotic workflow for susceptibility testing, resistant-pathogen phenotyping, and transmission studies. This guide connects 30S-targeted activity with plasmid-focused CREC assays, offering executable conditions and troubleshooting strategies for reproducible research.

• WSP-5 for Live-Cell H2S Imaging

  2026-09-14

  WSP-5, also called Washington State Probe-5, is a turn-on fluorescent probe for rapid H2S detection in biological systems. Its reported fast activation, green-shifted fluorescence, and compatibility with live-cell imaging support monitoring H2S dynamics in cells, while disease-model interpretation requires independent controls and calibration.

• Cinoxacin Workflows for Gram-Negative Research

  2026-09-13

  Build reproducible Cinoxacin assays for susceptibility testing, urinary tract infection research, and resistance profiling with concentration ranges matched to the compound’s documented activity. The workflow also shows how a precision-trial concept—time above a predefined biological threshold—can improve interpretation without confusing immunology evidence with direct antibacterial validation.

• MDockPeP2_VS: Screening Peptides Against TEM-1

  2026-09-12

  The PNAS Nexus study introduces MDockPeP2_VS, a structure-based workflow that combines molecular docking with conservation between protein folding and protein–peptide binding to make large-scale peptide screening more practical. Applied to Escherichia coli TEM-1 β-lactamase, the approach identified TF7 as a micromolar inhibitor, providing a computational starting point for β-lactam antibiotic resistance research and follow-up biochemical validation.

• QPRT, P2Y11 Signaling, and Breast Cancer Invasion

  2026-09-12

  A Frontiers in Endocrinology study links elevated QPRT, a rate-limiting enzyme in de novo NAD+ synthesis, to breast cancer migration and invasion through a purinergic signaling–myosin light chain axis. Its paired genetic and pharmacological experiments provide a useful framework for testing how metabolic remodeling influences cytoskeletal behavior, while also highlighting limits in assigning direct P2Y11 receptor causality.

• Carrier-Platin and ROS-Driven Cancer Cell Death

  2026-09-11

  Liu and colleagues developed carrier-platin, a poly(amino acid)-based formulation containing ultrasmall platinum nanoparticles that rapidly amplifies intracellular reactive oxygen species. The study links this ROS burst to cancer-cell death within 30 minutes, including in multidrug-resistant models, through a mechanism distinct from conventional platinum-induced DNA damage, apoptosis, and ferroptosis.

• NADH Workflows for Redox and Mitochondrial Research

  2026-09-11

  Build more interpretable redox experiments with NADH, from cell-based metabolic perturbation to direct NADH/NAD⁺ measurement. This workflow connects mitochondrial electron transport chain research with Leigh syndrome models, diabetic nephropathy research, and emerging photocatalytic cancer therapy while emphasizing sample handling and assay controls.

• Doxycycline Workflows for Cancer Research

  2026-09-10

  Doxycycline supports more than antimicrobial experiments: it can help separate metalloproteinase-driven biology from direct cytotoxicity, while serving as a practical comparator in targeted cancer-delivery studies. This guide translates its formulation constraints into reproducible cell, enzyme, microbial, and nanocarrier workflows.

• Purmorphamine Workflows for Smoothened Signaling

  2026-09-10

  Build reproducible Hedgehog pathway assays with Purmorphamine, from osteogenic differentiation in mesenchymal cells to sensory signaling studies in honeybees. This workflow-led guide combines dose planning, orthogonal readouts, cross-species interpretation, and practical troubleshooting.

• Carbapenemase Gene Transmission in CREC

  2026-09-09

  A 2025 BMC Microbiology study analyzed carbapenem-resistant Enterobacter cloacae from eight teaching hospitals in Guangdong and combined gene localization, antimicrobial susceptibility testing, conjugation assays, mobile-element analysis, and ERIC-PCR typing. Its findings show that blaNDM-1 was frequently plasmid-associated and readily transferable, while clonal and mobile-element evidence together revealed overlapping horizontal and vertical dissemination pathways.

• Minocycline HCl: Mechanism and Research Use

  2026-09-09

  Minocycline HCl is a semisynthetic tetracycline antibiotic with established 30S-ribosome activity and widely studied anti-inflammatory effects. This article separates directly supported minocycline evidence from a 2025 extracellular-vesicle manufacturing benchmark so researchers can design clearer antimicrobial, inflammation, and neuroprotection studies.

• Insulin–AMPK Control of PINK1 mRNA in Neurons

  2026-09-08

  This preprint identifies an insulin–AMPK metabolic switch that controls whether Pink1 mRNA remains tethered to mitochondria in neurons, thereby regulating PINK1 ubiquitin-kinase activity and mitophagy. Its findings connect impaired insulin signaling, including an ApoE4-associated insulin-resistance model, with defective mitochondrial quality control and provide a framework for designing insulin perturbation experiments in neuronal cultures.

• PPT (Propyl Pyrazole Triol) for ERα Research

  2026-09-07

  PPT (Propyl Pyrazole Triol) is a potent, subtype-selective ERα agonist for controlled studies of estrogen receptor signaling. Product information reports approximately 410-fold ERα-over-ERβ selectivity, while the female LUAD study provides biomarker rationale but does not directly validate PPT in lung adenocarcinoma.

• Tetracycline Hydrochloride: Assay Reliability

  2026-09-07

  A scenario-based guide to using Tetracycline Hydrochloride in antimicrobial, co-culture, and assay-control workflows. It explains how SKU A2517 supports practical stock preparation, mechanism-aware interpretation, and evidence-based supplier selection without confusing bacterial inhibition with mammalian cytotoxicity.

• Vincristine Sulfate: Workflow & Optimization

  2026-09-05

  Build more reproducible cancer research assays with vincristine sulfate by linking microtubule disruption to dose-response, imaging, and recovery measurements. This workflow separates product-specific evidence from practical optimization, helping researchers compare cell-based and xenograft models without overinterpreting a single viability endpoint.

8450 records 1/564 page Next 12345 下5页 Last page